Navigating a new treatment for the first time isn’t easy. It’s normal to forget to ask your doctor things or to start using your Enstilar® treatment and then have some questions. The My LEO Pharma Enstilar® pages are designed to answer some of the common questions you may have to help guide you through your Enstilar® treatment course.

Before you start your treatment with Enstilar®, please take the time to read the patient information leaflet (PIL) that comes in the pack. This website does not replace the PIL. The patient information leaflet (PIL) can also be accessed at www.medicines.org.uk and www.medicines.ie. Always use Enstilar® exactly as your doctor has advised you.

Enstilar® Application Basics

This downloadable PDF answers questions you may have about how to apply Enstilar®.

How to Apply Enstilar

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

For the United Kingdom

You can also report side effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store.

For the Republic of Ireland

The Health Products Regulatory Authority (HPRA) monitors the safety and quality of all medicines available in Ireland. Should you wish, you can also report any suspected side effects directly via HPRA Pharmacovigilance,
Earlsfort Terrace, IRL- Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; Email: medsafety@hpra.ie.

By reporting side effects you can help provide more information on the safety of this medicine.

Date of preparation: March 2026
UK/IE MAT-92985